Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus

Study Questions:

What is the safety and efficacy of saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, with respect to cardiovascular outcomes in patients with type 2 diabetes mellitus (DM2) who are at risk for cardiovascular events?